Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Breast 3Tumor-Agnostic 2Gynecologic 2Genitourinary 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Tobacco Use Disorder 1Substance-Related Disorders 1Lung Neoplasms 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Behavioral Therapy × Thoracic × 1 year × Clear all
NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡